checkAd
    Startseite > Aktien > Vincerx Pharma > Nachrichten
    Vincerx Pharma Aktie
    0,6590
     
    USD
    -3,63 %
    -0,0248 USD
    Letzter Kurs 02:00:00 Nasdaq
    0,6520
     
    USD
    1.600 STK
    Geldkurs 28.05.24
    0,6600
     
    USD
    7.800 STK
    Briefkurs 28.05.24
    ISIN: US92731L1061 · WKN: A2QHQ0 · SYM: VINC · USA

    Neueste Nachrichten

    Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
    14.05.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
    26.04.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants
    25.04.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 
    08.04.24 · globenewswire · Vincerx Pharma
    Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024
    01.04.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
    29.03.24 · globenewswire · Vincerx Pharma
    Vincerx to Present Three Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024
    05.03.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma
    07.01.24 · globenewswire · Vincerx Pharma
    Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    14.11.23 · globenewswire · Vincerx Pharma
    Vincerx Pharma To Present Three Posters at ASH 2023 in December
    02.11.23 · globenewswire · Vincerx Pharma
    Vincerx Pharma to Participate at the Cantor Fitzgerald Global Healthcare Conference 2023
    19.09.23 · globenewswire · Vincerx Pharma
    Vincerx Pharma Doses First Patient in the Phase 1 Clinical Trial Evaluating VIP943
    14.09.23 · globenewswire · Vincerx Pharma